| Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria CH Polman, SC Reingold, B Banwell, M Clanet, JA Cohen, M Filippi, ... Annals of neurology 69 (2), 292-302, 2011 | 11308 | 2011 |
| Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria AJ Thompson, BL Banwell, F Barkhof, WM Carroll, T Coetzee, G Comi, ... The Lancet Neurology 17 (2), 162-173, 2018 | 7987 | 2018 |
| Defining the clinical course of multiple sclerosis: the 2013 revisions FD Lublin, SC Reingold, JA Cohen, GR Cutter, PS Sørensen, ... Neurology 83 (3), 278-286, 2014 | 4067 | 2014 |
| Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis JA Cohen, F Barkhof, G Comi, HP Hartung, BO Khatri, X Montalban, ... New England Journal of Medicine 362 (5), 402-415, 2010 | 2864 | 2010 |
| Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosis: results of a phase III multicenter, double‐blind, placebo‐controlled trial KP Johnson, BR Brooks, JA Cohen, CC Ford, J Goldstein, RP Lisak, ... Neurology 45 (7), 1268-1276, 1995 | 2576 | 1995 |
| Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial JA Cohen, AJ Coles, DL Arnold, C Confavreux, EJ Fox, HP Hartung, ... The Lancet 380 (9856), 1819-1828, 2012 | 1325 | 2012 |
| Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial AJ Coles, CL Twyman, DL Arnold, JA Cohen, C Confavreux, EJ Fox, ... The lancet 380 (9856), 1829-1839, 2012 | 1307 | 2012 |
| Differential diagnosis of suspected multiple sclerosis: a consensus approach DH Miller, BG Weinshenker, M Filippi, BL Banwell, JA Cohen, ... Multiple Sclerosis Journal 14 (9), 1157-1174, 2008 | 961 | 2008 |
| Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. V Dousset, RI Grossman, KN Ramer, MD Schnall, LH Young, ... Radiology 182 (2), 483-491, 1992 | 847 | 1992 |
| Evaluation of the six-minute walk in multiple sclerosis subjects and healthy controls MD Goldman, RA Marrie, JA Cohen Multiple Sclerosis Journal 14 (3), 383-390, 2008 | 769 | 2008 |
| Heparin-induced thrombocytopenia: towards consensus TE Warkentin, BH Chong, A Greinacher Thrombosis and haemostasis 59 (01), 1-7, 1998 | 764 | 1998 |
| Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability KP Johnson, BR Brooks, JA Cohen, CC Ford, J Goldstein, RP Lisak, ... Neurology 50 (3), 701-708, 1998 | 727 | 1998 |
| A robust and verifiable cryptographically secure election scheme JD Cohen, MJ Fischer Yale University. Department of Computer Science, 1985 | 677 | 1985 |
| Ofatumumab versus teriflunomide in multiple sclerosis SL Hauser, A Bar-Or, JA Cohen, G Comi, J Correale, PK Coyle, AH Cross, ... New England Journal of Medicine 383 (6), 546-557, 2020 | 636 | 2020 |
| The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review RA Marrie, S Reingold, J Cohen, O Stuve, M Trojano, PS Sorensen, ... Multiple Sclerosis Journal 21 (3), 305-317, 2015 | 628 | 2015 |
| A point mutation in the neu oncogene mimics ligand induction of receptor aggregation DB Weiner, J Liu, JA Cohen, WV Williams, MI Greene Nature 339 (6221), 230-231, 1989 | 570 | 1989 |
| Benefit of interferon β-1a on MSFC progression in secondary progressive MS JA Cohen, GR Cutter, JS Fischer, AD Goodman, FR Heidenreich, ... Neurology 59 (5), 679-687, 2002 | 523 | 2002 |
| Mechanisms of fingolimod's efficacy and adverse effects in multiple sclerosis JA Cohen, J Chun Annals of neurology 69 (5), 759-777, 2011 | 496 | 2011 |
| A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview RA Marrie, J Cohen, O Stuve, M Trojano, PS Sørensen, S Reingold, ... Multiple Sclerosis Journal 21 (3), 263-281, 2015 | 473 | 2015 |
| Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis RW Motl, JA Cohen, R Benedict, G Phillips, N LaRocca, LD Hudson, ... Multiple Sclerosis Journal 23 (5), 704-710, 2017 | 390 | 2017 |
